TP53 Mutation Spectrum in Lung Cancer Is Not Different in Women and Men

• Published in: Cancer epidemiology, biomarkers & prevention Vol. 14; no. 4; pp. 1031 - 1033
• Main Authors: MARROGI, Aizen J, MECHANIC, Leah E, WELSH, Judith A, BOWMAN, Elise D, KHAN, Mohammed A, ENEWOLD, Lindsey, SHIELDS, Peter G, HARRIS, Curtis C
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 01.04.2005
• Subjects: Biological and medical sciences; Female; gender; Genes, p53 - genetics; Humans; lung cancer; Lung Neoplasms - etiology; Lung Neoplasms - genetics; Male; Medical sciences; Mutation; p53; Pneumology; Sex Factors; smoking; Smoking - adverse effects; Tumors; Tumors of the respiratory system and mediastinum; United States; North America; America; Human; Lung disease; Sequence specificity; Respiratory disease; Lung cancer; Tobacco smoking; Epidemiology; Cancerology; TP53 Gene; Risk factor; Bronchus disease; Genetics; Mutation; Public health; Tumor suppressor gene
• ISSN: 1055-9965; 1538-7755
• DOI: 10.1158/1055-9965.EPI-04-0640

Whether women are more susceptible to lung cancer than men has been controversial. Several case-control studies suggested that women have greater risk of lung cancer compared with men at similar levels of cigarette smoking, whereas some large cohort studies failed to observe this association. Other studies indicated that lung cancer may have biological characteristics and mechanisms of carcinogenesis that are gender specific. Therefore, we hypothesized that women are more susceptible to the carcinogenic effects of tobacco smoke exposure, as evidenced by a higher frequency of G:C-to-T:A somatic mutations in tumors from women in comparison with men at similar levels of tobacco smoke exposure. To investigate our hypothesis, we examined the TP53 mutational spectrum in a case-only (102 women and 201 men) series study where complete smoking information was available. A similar frequency and type of somatic TP53 mutations were observed in women and men. In conclusion, our study indicates that the TP53 mutation spectrum is similar in women and men. Our results are consistent with a recent large cohort study and summary of previous cohort studies, suggesting that women likely have equivalent susceptibility to lung cancer as men.